Literature DB >> 20675843

Health insurance coverage among persons with schizophrenia in the United States.

Elizabeth Khaykin1, William W Eaton, Daniel E Ford, Christopher B Anthony, Gail L Daumit.   

Abstract

OBJECTIVE: This study estimated the rates of health insurance coverage in the U.S. civilian noninstitutionalized population with schizophrenia and assessed whether basic access to health care varied across health insurance categories.
METHODS: Data from the Medical Expenditures Panel Survey collected between 2002 and 2006 were used.
RESULTS: The sample contained 328 records representing 493,006 noninstitutionalized civilian persons with schizophrenia. Eighty-seven percent had Medicaid or Medicare, 8% received care through the Veterans Health Administration, and 15% had private insurance for at least one day during the year. About 7% were uninsured all of the year. The uninsured tended to be male (92%), nonwhite (54%), and unmarried (97%), and 30% of the uninsured had not had a medical checkup in more than five years.
CONCLUSIONS: Almost all U.S. adults with schizophrenia were found to receive government health insurance, yet a measurable minority remained uninsured. These national estimates highlight opportunities for improving health service delivery for this vulnerable population.

Entities:  

Mesh:

Year:  2010        PMID: 20675843      PMCID: PMC7245045          DOI: 10.1176/ps.2010.61.8.830

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  11 in total

Review 1.  Strategies for maximizing clinical effectiveness in the treatment of schizophrenia.

Authors:  Rajiv Tandon; Steven D Targum; Henry A Nasrallah; Ruth Ross
Journal:  J Psychiatr Pract       Date:  2006-11       Impact factor: 1.325

2.  Health insurance coverage and medical expenditures of immigrants and native-born citizens in the United States.

Authors:  Leighton Ku
Journal:  Am J Public Health       Date:  2009-05-14       Impact factor: 9.308

Review 3.  The burden of mental disorders.

Authors:  William W Eaton; Silvia S Martins; Gerald Nestadt; O Joseph Bienvenu; Diana Clarke; Pierre Alexandre
Journal:  Epidemiol Rev       Date:  2008-09-19       Impact factor: 6.222

4.  The economic burden of schizophrenia in the United States in 2002.

Authors:  Eric Q Wu; Howard G Birnbaum; Lizheng Shi; Daniel E Ball; Ronald C Kessler; Matthew Moulis; Jyoti Aggarwal
Journal:  J Clin Psychiatry       Date:  2005-09       Impact factor: 4.384

5.  Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care.

Authors:  Haya Ascher-Svanum; Douglas E Faries; Baojin Zhu; Frank R Ernst; Marvin S Swartz; Jeff W Swanson
Journal:  J Clin Psychiatry       Date:  2006-03       Impact factor: 4.384

6.  Characteristics and service use patterns of nonelderly medicare beneficiaries with schizophrenia.

Authors:  P T Yanos; S Crystal; R Kumar; J T Walkup
Journal:  Psychiatr Serv       Date:  2001-12       Impact factor: 3.084

7.  The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003.

Authors:  Anthony F Lehman; Julie Kreyenbuhl; Robert W Buchanan; Faith B Dickerson; Lisa B Dixon; Richard Goldberg; Lisa D Green-Paden; Wendy N Tenhula; Daniela Boerescu; Cenk Tek; Neil Sandson; Donald M Steinwachs
Journal:  Schizophr Bull       Date:  2004       Impact factor: 9.306

8.  Effect of a medication copayment increase in veterans with schizophrenia.

Authors:  John E Zeber; Kyle L Grazier; Marcia Valenstein; Frederic C Blow; Paula M Lantz
Journal:  Am J Manag Care       Date:  2007-06       Impact factor: 2.229

9.  Correlates of health insurance among persons with schizophrenia in a statewide behavioral health care system.

Authors:  Philip T Yanos; Weli Lu; Shula Minsky; Gerard L Kiely
Journal:  Psychiatr Serv       Date:  2004-01       Impact factor: 3.084

10.  Changes over time and disparities in schizophrenia treatment quality.

Authors:  Alisa B Busch; Anthony F Lehman; Howard Goldman; Richard G Frank
Journal:  Med Care       Date:  2009-02       Impact factor: 2.983

View more
  28 in total

Review 1.  The development of psychotic disorders in adolescence: a potential role for hormones.

Authors:  Hanan D Trotman; Carrie W Holtzman; Arthur T Ryan; Daniel I Shapiro; Allison N MacDonald; Sandra M Goulding; Joy L Brasfield; Elaine F Walker
Journal:  Horm Behav       Date:  2013-07       Impact factor: 3.587

Review 2.  Quality of medical care for persons with serious mental illness: A comprehensive review.

Authors:  Emma E McGinty; Julia Baller; Susan T Azrin; Denise Juliano-Bult; Gail L Daumit
Journal:  Schizophr Res       Date:  2015-04-27       Impact factor: 4.939

3.  Recruitment and enrollment of African Americans and Caucasians in a health promotion trial for persons with serious mental illness.

Authors:  Mona Siddiqui; Lisa A Cooper; Lawrence J Appel; Airong Yu; Jeanne Charleston; Joseph Gennusa; Faith Dickerson; Gail L Daumit
Journal:  Ethn Dis       Date:  2015       Impact factor: 1.847

4.  Do Medical Homes Offer Improved Diabetes Care for Medicaid Enrollees with Co-occurring Schizophrenia?

Authors:  William J Olesiuk; Joel F Farley; Marisa Elena Domino; Alan R Ellis; Joseph P Morrissey
Journal:  J Health Care Poor Underserved       Date:  2017

5.  Is serious mental illness associated with earlier death among persons with HIV? Ten year follow up in Maryland Medicaid Recipients.

Authors:  Geetanjali Chander; YiYi Zhang; Susan dosReis; Donald M Steinwachs; Daniel E Ford; Eliseo Guallar; Gail Daumit
Journal:  J AIDS HIV Res       Date:  2012-08

6.  Effects of Maryland's Affordable Care Act Medicaid Health Home Waiver on Quality of Cardiovascular Care Among People with Serious Mental Illness.

Authors:  Emma E McGinty; Elizabeth M Stone; Alene Kennedy-Hendricks; Sachini Bandara; Karly A Murphy; Elizabeth A Stuart; Michael A Rosenblum; Gail L Daumit
Journal:  J Gen Intern Med       Date:  2020-03-03       Impact factor: 5.128

7.  Post-myocardial-infarction quality of care among disabled Medicaid beneficiaries with and without serious mental illness.

Authors:  Emma E McGinty; Elena Blasco-Colmenares; Yiyi Zhang; Susan C Dosreis; Daniel E Ford; Donald M Steinwachs; Eliseo Guallar; Gail L Daumit
Journal:  Gen Hosp Psychiatry       Date:  2012-07-02       Impact factor: 3.238

Review 8.  Review of the evidence: prevalence of medical conditions in the United States population with serious mental illness.

Authors:  Ellen M Janssen; Emma E McGinty; Susan T Azrin; Denise Juliano-Bult; Gail L Daumit
Journal:  Gen Hosp Psychiatry       Date:  2015-03-14       Impact factor: 3.238

9.  Impact of oral antipsychotic medication adherence on healthcare resource utilization among schizophrenia patients with Medicare coverage.

Authors:  Steve Offord; Jay Lin; Bruce Wong; Dario Mirski; Ross A Baker
Journal:  Community Ment Health J       Date:  2013-08-10

10.  Guideline-concordant antipsychotic use and mortality in schizophrenia.

Authors:  Bernadette A Cullen; Emma E McGinty; Yiyi Zhang; Susan C Dosreis; Donald M Steinwachs; Eliseo Guallar; Gail L Daumit
Journal:  Schizophr Bull       Date:  2012-10-30       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.